<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Imatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Şimşek, Eda Tanrıkulu

Eskazan, Ahmet Emre

Cengiz, Mahir

Ar, M. Cem

Ekizoğlu, Seda

Salihoğlu, Ayşe

Gültürk, Emine

Elverdi, Tuğrul

Aydın, Seniz Öngören

Demiröz, Ahu Senem

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Source

Publisher

American Society Hematology

Citation

item.page.haspartof

Source

Blood

item.page.ispartofseries

item.page.edition

DOI

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Bu yayında DOI yok — Altmetric/Dimensions/PlumX/BIP! rozetleri DOI gerektirir.